Overview

Initiation and Titration of Amaryl

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Primary Objective: - To describe the conditions of initiation and titration of Amaryl M, according to previous treatment: - initial dose - titration scheme - efficacy after 4 months assessed by HbA1C - tolerability (number and severity of hypoglycaemia) Secondary Objective: - Fasting Plasma Glucose - Weight evolution
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Glimepiride
Metformin